IBDEI18J ; ; 06-AUG-2015
 ;;3.0;IB ENCOUNTER FORM IMP/EXP;;JUN 29, 2015
 Q:'DIFQR(358.3)  F I=1:2 S X=$T(Q+I) Q:X=""  S Y=$E($T(Q+I+1),4,999),X=$E(X,4,999) S:$A(Y)=126 I=I+1,Y=$E(Y,2,999)_$E($T(Q+I+1),5,99) S:$A(Y)=61 Y=$E(Y,2,999) X NO E  S @X=Y
Q Q
 ;;^UTILITY(U,$J,358.3,21875,0)
 ;;=438.11^^118^1360^3
 ;;^UTILITY(U,$J,358.3,21875,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,21875,1,4,0)
 ;;=4^438.11
 ;;^UTILITY(U,$J,358.3,21875,1,5,0)
 ;;=5^Late Effect CVA,Aphasia
 ;;^UTILITY(U,$J,358.3,21875,2)
 ;;=^317907
 ;;^UTILITY(U,$J,358.3,21876,0)
 ;;=438.12^^118^1360^4
 ;;^UTILITY(U,$J,358.3,21876,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,21876,1,4,0)
 ;;=4^438.12
 ;;^UTILITY(U,$J,358.3,21876,1,5,0)
 ;;=5^Late Effect CVA,Dysphasia
 ;;^UTILITY(U,$J,358.3,21876,2)
 ;;=^317908
 ;;^UTILITY(U,$J,358.3,21877,0)
 ;;=438.21^^118^1360^5
 ;;^UTILITY(U,$J,358.3,21877,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,21877,1,4,0)
 ;;=4^438.21
 ;;^UTILITY(U,$J,358.3,21877,1,5,0)
 ;;=5^Late Effect CVA,Hemipl,Dom Side
 ;;^UTILITY(U,$J,358.3,21877,2)
 ;;=^317911
 ;;^UTILITY(U,$J,358.3,21878,0)
 ;;=438.22^^118^1360^6
 ;;^UTILITY(U,$J,358.3,21878,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,21878,1,4,0)
 ;;=4^438.22
 ;;^UTILITY(U,$J,358.3,21878,1,5,0)
 ;;=5^Late Effect CVA,Hemipl,Non-Dom Side
 ;;^UTILITY(U,$J,358.3,21878,2)
 ;;=^317912
 ;;^UTILITY(U,$J,358.3,21879,0)
 ;;=438.32^^118^1360^9
 ;;^UTILITY(U,$J,358.3,21879,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,21879,1,4,0)
 ;;=4^438.32
 ;;^UTILITY(U,$J,358.3,21879,1,5,0)
 ;;=5^Late Effect CVA,Monopl,U/L,Non-Dom Side
 ;;^UTILITY(U,$J,358.3,21879,2)
 ;;=^317915
 ;;^UTILITY(U,$J,358.3,21880,0)
 ;;=438.41^^118^1360^7
 ;;^UTILITY(U,$J,358.3,21880,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,21880,1,4,0)
 ;;=4^438.41
 ;;^UTILITY(U,$J,358.3,21880,1,5,0)
 ;;=5^Late Effect CVA,Monopl,L/L,Dom Side
 ;;^UTILITY(U,$J,358.3,21880,2)
 ;;=^317917
 ;;^UTILITY(U,$J,358.3,21881,0)
 ;;=438.42^^118^1360^8
 ;;^UTILITY(U,$J,358.3,21881,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,21881,1,4,0)
 ;;=4^438.42
 ;;^UTILITY(U,$J,358.3,21881,1,5,0)
 ;;=5^Late Effect CVA,Monopl,L/L,Non-Dom Side
 ;;^UTILITY(U,$J,358.3,21881,2)
 ;;=^317918
 ;;^UTILITY(U,$J,358.3,21882,0)
 ;;=438.84^^118^1360^1
 ;;^UTILITY(U,$J,358.3,21882,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,21882,1,4,0)
 ;;=4^438.84
 ;;^UTILITY(U,$J,358.3,21882,1,5,0)
 ;;=5^Ataxia
 ;;^UTILITY(U,$J,358.3,21882,2)
 ;;=^328507
 ;;^UTILITY(U,$J,358.3,21883,0)
 ;;=070.51^^118^1361^1
 ;;^UTILITY(U,$J,358.3,21883,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,21883,1,4,0)
 ;;=4^070.51
 ;;^UTILITY(U,$J,358.3,21883,1,5,0)
 ;;=5^Acute Hepatitis C w/o Coma
 ;;^UTILITY(U,$J,358.3,21883,2)
 ;;=^331778
 ;;^UTILITY(U,$J,358.3,21884,0)
 ;;=070.54^^118^1361^2
 ;;^UTILITY(U,$J,358.3,21884,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,21884,1,4,0)
 ;;=4^070.54
 ;;^UTILITY(U,$J,358.3,21884,1,5,0)
 ;;=5^Chr Hepatitis C w/o Coma
 ;;^UTILITY(U,$J,358.3,21884,2)
 ;;=^303252
 ;;^UTILITY(U,$J,358.3,21885,0)
 ;;=V02.62^^118^1361^3
 ;;^UTILITY(U,$J,358.3,21885,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,21885,1,4,0)
 ;;=4^V02.62
 ;;^UTILITY(U,$J,358.3,21885,1,5,0)
 ;;=5^Hepatitis C Carrier
 ;;^UTILITY(U,$J,358.3,21885,2)
 ;;=^317947
 ;;^UTILITY(U,$J,358.3,21886,0)
 ;;=300.00^^118^1362^1
 ;;^UTILITY(U,$J,358.3,21886,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,21886,1,4,0)
 ;;=4^300.00
 ;;^UTILITY(U,$J,358.3,21886,1,5,0)
 ;;=5^Anxiety NOS
 ;;^UTILITY(U,$J,358.3,21886,2)
 ;;=^9200
 ;;^UTILITY(U,$J,358.3,21887,0)
 ;;=295.90^^118^1362^4
 ;;^UTILITY(U,$J,358.3,21887,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,21887,1,4,0)
 ;;=4^295.90
 ;;^UTILITY(U,$J,358.3,21887,1,5,0)
 ;;=5^Schizophrenia NOS
 ;;^UTILITY(U,$J,358.3,21887,2)
 ;;=^108287
 ;;^UTILITY(U,$J,358.3,21888,0)
 ;;=296.20^^118^1362^3
 ;;^UTILITY(U,$J,358.3,21888,1,0)
 ;;=^358.31IA^5^2
 ;;
 ;;$END ROU IBDEI18J
